Global Preclinical Cell and Gene Therapy Lead, and Head of Toxicology Subject Matter Experts, Safety Assessment/Toxicology, Labcorp
BIOGRAPHY
Speakers
-
Tracy Iles, BSc
Global Head of Method Development, Molecular Bioanalysis, LabcorpBIOGRAPHY -
Jay Herman, PhD
Toxicology Specialist, Study Director, LabcorpBIOGRAPHY -
Peter Sonnentag, MS
Study Director and Preclinical Ocular Toxicology Lead, LabcorpBIOGRAPHY -
Colin Guy, PhD
Senior Manager, GMP Research and Development, Biopharmaceutical CMC SolutionsBIOGRAPHY
Event Date & Time
Date: Oct. 24, 2023
Time: 8:00 AM (PDT), 11:00 AM (EDT), 5:00 PM (CEST)
Abstract
Join us for the first of a 3-part series that will focus on approaches to accelerating your advanced therapy program by leveraging the combination of innovative technology and deep cross-industry insights from our cell and gene therapy scientists and operational leaders.
In this roundtable, the panel will discuss novel innovations and strategies to accelerate timelines within preclinical development of your gene therapy. Specific areas of focus include:
In this roundtable, the panel will discuss novel innovations and strategies to accelerate timelines within preclinical development of your gene therapy. Specific areas of focus include:
-
Optimizing analytical test development and validation for dose analysis, molecular bioanalysis, transgene bioanalysis and immunogenicity, etc.
-
Utilizing unique in vivo models requiring complex methods and routes of administration (e.g., intracranial, or ocular delivery, disease, or immunosuppressed models)
-
Driving cross-industry collaboration to support accelerating timelines and reducing risk
Register for roundtable 1: Key Considerations for Driving Gene Therapy Programs Successfully Through IND/CTA and Beyond
Register for roundtable 2: Accelerating Cell Therapy Clinical Trials With Comprehensive Biomarker-Driven Strategies
Register for roundtable 3: Companion Diagnostic Approaches in the Development of Cell and Gene Therapies
Register for roundtable 2: Accelerating Cell Therapy Clinical Trials With Comprehensive Biomarker-Driven Strategies
Register for roundtable 3: Companion Diagnostic Approaches in the Development of Cell and Gene Therapies
Webinars will be available for unlimited on-demand viewing after live event
You May Also Like
SEP 26, 2023 | 8:00 AM
Join us for an educational webinar that delves into the fascinating world of Extracellular Vesicles (EVs) and their impact on biomedical research and medicine. In collaboration with ExoVecto...
OCT 24, 2023 | 10:00 AM
Dynamic changes in chromatin drive gene expression programs during cellular development and contribute to pathological changes underlying disease. To date, efforts to characterize chromatin...
SEP 13, 2023 | 10:00 AM
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...
September 13 at 10:00am CEST, 9:00am BST
Webinar airing too early or too late for you? This webinar will also be available: September 13 at 10:00am PDT, 1:00pm EDT https://www.labroots.com/ms/webinar/dpcr-liquidbiopsy-panel-2 and S...
September 13 at 9:30am IST, 12:00pm CST/SGT
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...
AUG 29, 2023 | 7:00 AM
C.E. CREDITS
Spatialomics leverages multiplex imaging to achieve translational profiling of tissue specimens by assessing the relative spatial orientations of biological structures with RNA and protein e...
Loading Comments...
Finish Registering
-
OCT 01, 2023The Thomas Center
-
NOV 01, 2023CRISPR Virtual Event Series 2023
-
MAR 06, 2024Neuroscience Virtual Event Series 2024
- See More
-
OCT 21, 2023
- See More
